Package 68788-7210-3
Brand: carbamazepine
Generic: carbamazepinePackage Facts
Identity
Package NDC
68788-7210-3
Digits Only
6878872103
Product NDC
68788-7210
Description
30 TABLET in 1 BOTTLE (68788-7210-3)
Marketing
Marketing Status
Brand
carbamazepine
Generic
carbamazepine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e42caa67-4849-46e1-b3de-3a42638fa0cc", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["308979"], "spl_set_id": ["32dc301e-881d-47b0-ad16-f9ff31d19324"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-7210-1)", "package_ndc": "68788-7210-1", "marketing_start_date": "20180806"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-7210-2)", "package_ndc": "68788-7210-2", "marketing_start_date": "20180806"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-7210-3)", "package_ndc": "68788-7210-3", "marketing_start_date": "20180806"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-7210-6)", "package_ndc": "68788-7210-6", "marketing_start_date": "20180806"}, {"sample": false, "description": "28 TABLET in 1 BOTTLE (68788-7210-8)", "package_ndc": "68788-7210-8", "marketing_start_date": "20180806"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68788-7210-9)", "package_ndc": "68788-7210-9", "marketing_start_date": "20180806"}], "brand_name": "CARBAMAZEPINE", "product_id": "68788-7210_e42caa67-4849-46e1-b3de-3a42638fa0cc", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "68788-7210", "generic_name": "CARBAMAZEPINE", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CARBAMAZEPINE", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/1"}], "application_number": "ANDA075948", "marketing_category": "ANDA", "marketing_start_date": "20180806", "listing_expiration_date": "20261231"}